首页> 美国卫生研究院文献>Heliyon >Design synthesis and biological evaluation of benzoxazolinone-containing 134-thiadiazoles as TNF-α inhibitors
【2h】

Design synthesis and biological evaluation of benzoxazolinone-containing 134-thiadiazoles as TNF-α inhibitors

机译:含苯并恶唑啉酮的134-噻二唑类作为TNF-α抑制剂的设计合成和生物学评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A library of nineteen benzoxazolinone-based 1,3,4-thiadiazoles has been synthesized and screened for their anti-inflammatory activity. The compound >1f exhibited a potent anti-inflammatory activity with an inhibition of 65.83% and 32.50% after 3 h and 5 h respectively. It also exhibited a significant in vitro (p < 0.01), TNF- α inhibitory activity with 51.44 % inhibition. The compound >1f showed hydrogen bonding with GLN 61 and interactions with TYR 119, TYR 151 and GLY 121. The histopathology report showed that none of the compounds caused gastric ulceration. The results from the in vivo & in vitro antiinflammatory activity along with In Silico studies exhibit that benzoxazolinone-based 1,3,4-thiadiazoles may be used in the future development of anti-inflammatory drugs.
机译:合成了一个基于苯并恶唑啉酮的1,3,4-噻二唑的文库,并对其抗炎活性进行了筛选。化合物> 1f 显示出有效的抗炎活性,分别在3小时和5小时后抑制率为65.83%和32.50%。它还具有显着的体外TNF-α抑制活性(p <0.01),抑制率为51.44%。化合物> 1f 显示出与GLN 61的氢键键合以及与TYR 119,TYR 151和GLY 121的相互作用。组织病理学报告显示,这些化合物均未引起胃溃疡。体内和体外抗炎活性以及In Silico研究的结果表明,基于苯并恶唑啉酮的1,3,4-噻二唑可用于抗炎药物的未来开发中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号